Standard Operating Procedure for Assay Testing of Capsule Fill Materials
Department | Capsule Manufacturing |
---|---|
SOP No. | SOP/CM/184/2025 |
Supersedes | SOP/CM/184/2022 |
Page No. | Page 1 of 8 |
Issue Date | 01/02/2025 |
Effective Date | 05/02/2025 |
Review Date | 01/02/2026 |
1. Purpose
To outline the procedure for performing assay testing on capsule fill materials to ensure that the active pharmaceutical ingredient (API) content meets the required specifications.
2. Scope
This SOP applies to the assay testing of all capsule fill materials to confirm the concentration of the active pharmaceutical ingredient (API) and ensure compliance with batch release specifications.
3. Responsibilities
- Quality Control (QC) Team: Responsible for performing assay testing, analyzing results, and documenting findings.
- Quality Assurance (QA) Team: Ensures the assay testing process complies with regulatory requirements and approves results.
- Production Team: Provides capsule fill material samples for assay testing at specified intervals.
4. Accountability
The QA Manager is accountable for ensuring that assay testing is performed according to regulatory standards. The QC Supervisor oversees testing execution and documentation. The Production Supervisor ensures timely sample submission.
5. Procedure
5.1 Pre-Testing Setup
Before starting the assay test, ensure the following:
-
Review Test Specifications
- Verify assay specifications for the active pharmaceutical ingredient (API) in the capsule fill material, ensuring compliance with approved limits.
-
Prepare Equipment
- Ensure that all laboratory equipment, such as HPLC systems or UV spectrometers, is calibrated and operational. Document calibration in the Equipment Calibration Log (Annexure 1).
-
Prepare Sample
- Obtain a representative sample of capsule fill material according to the sampling plan (typically 10-20 capsules). Ensure proper handling to prevent contamination.
5.2 Assay Testing Procedure
Follow these steps to perform the assay test:
-
Extract API from Capsules
- Open each capsule and remove the fill material. Accurately weigh the fill material using a calibrated balance. Record the weight in the Assay Testing Log (Annexure 2).
-
Prepare Sample Solution
- Weigh an appropriate quantity of the fill material, dissolve it in a suitable solvent (e.g., methanol, water), and filter the solution if necessary.
-
Perform Assay Analysis
- Analyze the sample solution using the appropriate analytical technique (e.g., HPLC, UV spectrophotometry) to determine the concentration of the API.
-
Calculate API Content
- Calculate the API content in the capsule fill material as a percentage of the label claim. Compare the result with the defined acceptance limits (typically ±10% of the label claim).
-
Document Results
- Record all assay results in the Assay Testing Log (Annexure 2), including the sample details, test method used, and any deviations.
5.3 Post-Testing Activities
Once the assay testing is complete, ensure the following actions are taken:
-
Review Test Results
- The QA Manager reviews the test results and ensures compliance with the specifications. If the assay fails, initiate an investigation and determine the cause.
-
Corrective Actions
- If the assay fails, investigate the cause (e.g., formulation error, equipment malfunction) and take corrective actions. Retest the sample if necessary.
-
Training and Feedback
- If errors are identified in the testing process, provide feedback and additional training to the QC personnel.
-
Record Keeping
- Ensure all assay testing records are properly filed and archived in accordance with regulatory retention requirements.
6. Abbreviations
- SOP: Standard Operating Procedure
- GMP: Good Manufacturing Practice
- QA: Quality Assurance
- QC: Quality Control
- API: Active Pharmaceutical Ingredient
- HPLC: High-Performance Liquid Chromatography
- UV: Ultraviolet
7. Documents
- Annexure 1: Equipment Calibration Log
- Annexure 2: Assay Testing Log
- Annexure 3: Deviation Report
8. References
- FDA Guidance on Assay Testing for Pharmaceutical Products
- Good Manufacturing Practice (GMP) Guidelines
- USP <711> – Dissolution Testing
- ICH Q6A – Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products
9. SOP Version
Version: 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure 1: Equipment Calibration Log
Equipment ID | Calibration Date | Operator | Calibration Details | Next Calibration Due |
---|---|---|---|---|
HPLC 108 | 01/02/2025 | John Doe | Calibration of detector and column | 01/02/2026 |
Annexure 2: Assay Testing Log
Capsule ID | API Content (mg) | Label Claim (mg) | Deviation (%) | Remarks |
---|---|---|---|---|
Capsule 001 | 500 | 500 | 0% | Pass |
Annexure 3: Deviation Report
Batch ID | Deviation Type | Corrective Action | Responsible Person | Completion Date |
---|---|---|---|---|
Batch 001 | API Deviation | Reformulation | Production Supervisor | 03/02/2025 |
12. Revision History
Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
---|---|---|---|---|
01/01/2024 | 1.0 | Initial version of SOP | Creation of SOP for assay testing of capsule fill material | QA Head |
01/02/2025 | 2.0 | Updated testing methods and documentation | Improvement of test methods and compliance | QA Head |